Hybridoma Overview

By fusing immune B lymphocytes and myeloma cells into hybridoma cells, the resulting hybrid cells have the genetic characteristics of both parent cells, which can secrete antibodies like B lymphocytes and proliferate indefinitely like myeloma cells, successfully overcoming the problem of short survival cycle of B lymphocytes in vitro. Monoclonal antibody can be obtained by culture of hybridoma cells. KYINNO offers a wide range of high-quality antibodies, including hybridoma. Our products have passed purity analysis, stability analysis, affinity and bioactivity verification as well as been used in function assay.

Filter by Host
Filter by Antibody Types